Meningitis vax for Africa costs $0.40; Microgravity bioreactor makes stem cells;

> The Serum Institute of India, working with the Meningitis Vaccine Project, will produce 25 million doses of the MenAfriVac prophylactic over the next ten years for about 40 cents per dose, compared with the $10 to $20 cost elsewhere in the world. Article

> A bioreactor based on NASA microgravity research is being used to manufacture stem cells. Article

> WikiLeaks has published a list of overseas biopharma facilities considered vital to U.S. national security in its latest release. Article

> Kemwell has completed construction of a biopharmaceutical manufacturing plant in Bangalore, part of strategic collaboration that joins the company's early clinical supply services with Boehringer Ingelheim's cell line development capabilities. Item

> BioStorage Technologies in Indianapolis has added global sample relocation services, based on its ReloFleet temperature-controlled trailers, to its service offerings. BioStorage Technologies release

> Avid Bioservices says it will provide biosimilars process development and analysis for a privately held U.S. and China-based biopharma company. Avid release

> The Datex FootPrint warehouse management system now boasts audit trail and electronic signature features, making it compliant with 21 CFR Part 11. Datex release

> Injectables specialist Coldstream Laboratories has named David A. Gelber VP for operations. Coldstream release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.